These findings provide novel insights into the complex events of the adaptive signaling network occurring during the acquisition of tamoxifen resistance in breast cancer cells and highlight the role of S100P in conferring both resistance and enhanced migration. The gene discussed is S100P; the disease is breast carcinoma.